PC(P-18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))

Term ID

CHEBI:89469

Synonyms

1-(1-Enyl-oleoyl)-2-eicosapentaenoyl-sn-glycero-3-phosphocholine
[2-({2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyloxy]-3-[(1Z,9Z)-octadeca-1,9-dien-1-yloxy]propyl phosphonato}oxy)ethyl]trimethylazanium
GPCho(18:1/20:5)
GPCho(18:1n9/20:5n3)
GPCho(18:1w9/20:5w3)
GPCho(38:6)
Lecithin
PC aa C38:6
PC(18:1/20:5)
PC(18:1n9/20:5n3)
PC(18:1w9/20:5w3)
PC(38:6)
Phosphatidylcholine(18:1/20:5)
Phosphatidylcholine(18:1n9/20:5n3)
Phosphatidylcholine(18:1w9/20:5w3)
Phosphatidylcholine(38:6)

(all 16)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycerophosphocholine

glycerophosphocholine Show first 5 Terms

Phenotype

Phenotype resulting from PC(P-18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))

Phenotype where environments contain PC(P-18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))

Phenotype modified by environments containing PC(P-18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))

Phenotype affecting PC(P-18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))

Human Disease Model